Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zamicastat (BIA 5-1058) is an inhibitor of dopamine β-hydroxylase (DBH), and is also a concentration-dependent dual inhibitor of P-gp and BCRP(IC50 values of 73.8 μM and 17.0 μM, respectively).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 23,500 | |||
5 mg | 在庫あり | ¥ 51,500 | |||
10 mg | 在庫あり | ¥ 91,500 | |||
25 mg | 在庫あり | ¥ 153,000 | |||
50 mg | 在庫あり | ¥ 217,500 | |||
100 mg | 在庫あり | ¥ 294,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 53,500 |
説明 | Zamicastat (BIA 5-1058) is an inhibitor of dopamine β-hydroxylase (DBH), and is also a concentration-dependent dual inhibitor of P-gp and BCRP(IC50 values of 73.8 μM and 17.0 μM, respectively). |
ターゲット&IC50 | BCRP:17.0 μM , Dopamine β-hydroxylase:, P-gp:73.8 μM |
In vivo | In the Dahl SS rat, Zamicastat (10, 30 and 100 mg/kg/day; oral bolus, 7 days) is tested acutely against salt-induced hypertension. Zamicastat produces a dose-dependent decrease in blood pressure[2]. |
別名 | BIA 5-1058 |
分子量 | 401.47 |
分子式 | C21H21F2N3OS |
CAS No. | 1080028-80-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 150 mg/mL (373.63 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zamicastat 1080028-80-3 Membrane transporter/Ion channel Metabolism Neuroscience P-gp Hydroxylase BCRP ABCB1 Dopamine β-monooxygenase Inhibitor Cluster of differentiation 243 ABCG2 inhibit P-glycoprotein Multidrug resistance protein 1 BIA 5-1058 MDR1 CD243 Breast cancer resistance protein Pgp Dopamine β-hydroxylase Dopamine beta-hydroxylase Dopamine beta-monooxygenase inhibitor